𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early experience in the use of Levovist ultrasound contrast in the evaluation of liver masses

✍ Scribed by Plew, J ;Sanki, J ;Young, N ;Gruenewald, S ;Dwyer, R ;Brancatisano, R

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
83 KB
Volume
44
Category
Article
ISSN
0004-8461

No coin nor oath required. For personal study only.

✦ Synopsis

SUMMARY

The aim of the present paper was to assess the utility of Levovist in defining the pathology of liver masses. Levovist is a new ultrasound contrast agent consisting of galactose microparticles, air bubbles and palmitic acid. Prospective studies were performed in patients referred for further evaluation of known liver masses. Levovist was peripherally injected and colour Doppler ultrasound studies were performed. Findings were correlated with clinicopathology and three other imaging modalities: biphasic spiral CT, CT arterial portography and contrast MRI. Twenty‐five patients were studied (15 male and 10 female) in the age range 25–74 years. Liver masses ranged from 0.5 to 7 cm in maximum diameter. Thirteen lesions were benign and 12 were malignant (four hepatomas (HCC) and eight metastases). Levovist enhancement occurred in 18 lesions. Of these, six were benign (four focal nodular hyperplasias (FNH) and two haemangiomas). All 12 malignant lesions demonstrated enhancement. The HCC showed a mosaic pattern of central and peripheral enhancement, and the FNH demonstrated a spoke‐wheel pattern. It was not possible to distinguish between haemangiomas and malignant lesions. Non‐enhancing lesions may well be benign, with all malignancies showing some enhancement. Characteristic enhancement patterns were found for HCC (mosaic) and FNH (spoke‐wheel). It was not possible to distinguish between metastases and benign lesions (haemangiomas) when the pattern of enhancement was peripheral.

📜 SIMILAR VOLUMES

Evaluation of the microcirculatory distu
Evaluation of the microcirculatory disturbance of biliary ischemia after liver transplantation with contrast-enhanced ultrasound: Preliminary experience
✍ Jie Ren; Ming-De Lu; Rong-Qin Zheng; Min-Qiang Lu; Mei Liao; Yong-Jiang Mao; Zhi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB

The aim of this study was to determine the efficacy of contrast-enhanced ultrasound for depicting the perfusion of hilar bile ducts in ischemic-type biliary lesions after orthotopic liver transplantation. Thirteen transplant recipients with ischemic-type biliary lesions and 12 patients without ische

Intra-operative contrast-enhanced ultras
Intra-operative contrast-enhanced ultrasound improves image enhancement in the evaluation of liver tumors
✍ Robert C.G. Martin II; Nathan P. Reuter; Charles Woodall 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract ## Background Intra‐operative hepatic tumor ultrasound assessment can be difficult in patients with abnormal hepatic parenchyma because of the inability to enhance echogenic differences. ## Methods Prospective pilot study of intra‐operative ultrasound contrast enhancement in the eval

Contrast-enhanced ultrasound in the diag
Contrast-enhanced ultrasound in the diagnosis of malignant mesenchymal liver tumors
✍ Joerg Trojan; Renate Hammerstingl; Knut Engels; Arne R. Schneider; Stefan Zeuzem 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB

## Abstract ## Purpose. Contrast‐enhanced ultrasound can differentiate malignant from benign hepatic tumors, but has not been studied in malignant mesenchymal liver tumors. ## Methods. We describe the findings of contrast‐enhanced ultrasound in a cohort of five patients with histological‐proven

Detection and differential diagnosis of
Detection and differential diagnosis of hepatic masses using pulse inversion harmonic imaging during the liver-specific late phase of contrast enhancement with levovist
✍ Cem Yücel; Hakan Özdemir; Safiye Gürel; Şule Özer; Mehmet Araç 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

## Abstract ## Purpose The purpose of this study was to investigate whether late‐phase pulse inversion harmonic imaging (PIHI) increases conspicuity in hepatic masses, helps to differentiate benign from malignant lesions, and demonstrates a greater number of and smaller metastatic lesions than do